| Literature DB >> 3276988 |
Abstract
The calcium channel blockers initially were approved for the treatment of classical and variant angina pectoris. Recent studies indicate that these agents also are useful in such diverse conditions as pulmonary and systemic hypertension, hypertrophic cardiomyopathy, arrhythmias, asthma, Raynaud's syndrome, esophageal spasm, myometrial hyperactivity, cerebral arterial spasm, and migraine.Entities:
Mesh：
Substances：
Year: 1988 PMID： 3276988 DOI： 10.1016/s0025-7125(16)30787-8
Source DB: PubMed Journal: Med Clin North Am ISSN： 0025-7125 Impact factor: 5.456